🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
CAM
$CAMX.ST
🔒 EuropeCamurus AB
AVG HISTORICAL GAP
-2.14%
MAX GAP RECORD
-17.91%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $CAMX.ST
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$CAMX.ST
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 05, 2026 Earnings Release 2026-11-05 (AFTER CLOSE (16:00)) | 🔮 UPCOMING 🔒 |
| Jul 15, 2026 Earnings Release 2026-07-15 (BEFORE OPEN) |
+8.93%
|
| May 12, 2026 Earnings Release 2026-05-12 (BEFORE OPEN) |
-11.96%
|
| Feb 12, 2026 Earnings Release 2026-02-12 (BEFORE OPEN) |
-17.91%
|
| Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE) |
-0.45%
|
| Jul 17, 2025 Earnings Release 2025-07-17 (BEFORE OPEN) |
-9.78%
|
| May 15, 2025 Earnings Release 2025-05-15 (BEFORE OPEN) |
-5.15%
|
| Feb 13, 2025 Earnings Release 2025-02-13 (BEFORE OPEN) |
+6.05%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
5.5%
Bullish Gaps (6)
Bearish Gaps (6)
Neutral / Flat (3)
📖 Intelligence Summary
Camurus AB (publ), a biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia. The company offers Buvidal, a buprenorphine injection for the treatment of opioid dependence and chronic pain; and Brixadi to treat opioid use disorder. It also…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗